A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance

Pathol Res Pract. 2023 May:245:154442. doi: 10.1016/j.prp.2023.154442. Epub 2023 Apr 6.

Abstract

Osteosarcoma (OS) is one of the most common bone cancers that constantly affects children, teenagers, and young adults. Numerous epigenetic elements, such as miRNAs, have been shown to influence OS features like progression, initiation, angiogenesis, and treatment resistance. The expression of numerous genes implicated in OS pathogenesis might be regulated by miRNAs. This effect is ascribed to miRNAs' roles in the invasion, angiogenesis, metastasis, proliferation, cell cycle, and apoptosis. Important OS-related mechanistic networks like the WNT/b-catenin signaling, PTEN/AKT/mTOR axis, and KRAS mutations are also affected by miRNAs. In addition to pathophysiology, miRNAs may influence how the OS reacts to therapies like radiotherapy and chemotherapy. With a focus on how miRNAs affect OS signaling pathways, this review seeks to show how miRNAs and OS are related.

Keywords: Oncogenic miRNAs; Osteosarcoma; Resistance; Tumor suppressor (TS) miRNAs.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Bone Neoplasms* / pathology
  • Cell Line, Tumor
  • Cell Proliferation
  • Child
  • Drug Resistance, Neoplasm / genetics
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • MicroRNAs* / metabolism
  • Osteosarcoma* / pathology
  • Wnt Signaling Pathway / genetics
  • Young Adult

Substances

  • MicroRNAs